- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03111290
Modulating Oscillations and Working Memory in Patients With Subdural Electrodes
Purpose: To investigate whether rhythmic direct electrical stimulation (DES) causes entrainment of endogenous neural oscillatory activity and whether such activity improve cognition.
Participants: Drug-resistant epilepsy patients undergoing epilepsy surgery cortical mapping with continuous electrocorticography (ECoG) with intracranial electrodes.
Procedures (methods): Rhythmic electrical stimulation will be delivered via intracranial electrodes during routine extra-operative cortical mapping. Long-term ECoG, Pre-stimulation ECoG, peri-stimulation ECoG, and post-stimulation ECoG data will be analyzed to assess for entrainment of neural oscillations.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to characterize the entrainment of endogenous neural oscillatory activity using direct electrical stimulation (DES) of the brain and understand the effects on cognition.
In this study, the investigators will apply rhythmic DES to patients who are undergoing routine DES for cortical mapping as a part of their epilepsy surgery evaluation with the aim of entraining cortical neural oscillations at specific frequencies relevant to cognitive processing and neuropsychiatric disease. The investigators hypothesize that rhythmic DES within a naturally occurring oscillatory frequency will cause entrainment at that frequency (e.g. 10Hz rhythmic DES will entrain a 10 Hz alpha oscillation). Also, the investigators posit that rhythmic DES at the theta (5Hz), alpha(10Hz), and gamma (50Hz) frequencies will cause enhancement of neural oscillations in the gamma band.
The study follows a within-participant crossover design. Participants will perform one of the tasks described below and each task consists of multiple trials of varying difficulty. Stimulation will be applied concurrently through electrodes implanted for clinical determination of seizure focus. Equal number of stimulation and sham trials will be pseudo-randomly interleaved to get a balanced design (balanced across trial difficulty and trial type).
The investigators will apply electrical stimulation in the form of pulse trains. The applied electrical stimulation intensity, duration and frequency follow the parameters used for clinical assessments of language and seizure focus and fall below the clinically approved limits.
The investigators will measure participants performance on a simple working memory task during the above-described cortical electrical stimulation protocol. Alternately, participants can perform a face recognition task.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- History of medically intractable epilepsy
- Capable of giving informed consent
- Aged 18 - 80 years, either sex
Exclusion Criteria:
- Past or current history of other neurological illnesses including ischemic stroke, intracerebral hemorrhage, brain neoplasm.
- Major systemic illness
- Severe cognitive impairment defined as mini-mental state examination of less than 20
- Severe psychiatric illness
- Excessive use of alcohol or other substances
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Sham
Device: Direct Cortical Stimulation Sham.
Trials in which stimulation is not applied.
These trials are initiated using a generic trigger generator.
|
Sham trials where no electric pulse is delivered
|
Active Comparator: Stimulation
Device: Direct Cortical Stimulation.
150 stimulations with stimulations lasting 5 seconds at different target electrodes at two target frequencies (e.g. 5 Hz and 10 Hz) 2 milliampere in amplitude (Pulse shape - Biphasic square pulse 200 microsecond in duration per phase).
Stimulation will be applied concurrently with the task and stimulation trials will be randomly interleaved with sham trials.
|
A train of periodic electrical pulses is delivered between two local electrodes implanted in the brain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Working Memory Task Performance - Accuracy
Time Frame: 1 Hour
|
In this task, a sequence of items (alphabets or numerals) is presented followed by a delay.
Following this, a single item which may or may not have been in the sequence is presented and the subject will be asked to indicate whether the item was in the previously presented sequence.
A total of 150 trials will be performed with randomly interleaved sham trials where no stimulation is applied.
Accuracy will be quantified in percentage correct.
|
1 Hour
|
Working Memory Task Performance - Reaction Time
Time Frame: 1 Hour
|
In this task, a sequence of items (alphabets or numerals) is presented followed by a delay.
Following this, a single item which may or may not have been in the sequence is presented and the subject will be asked to indicate whether the item was in the previously presented sequence.
A total of 150 trials will be performed with randomly interleaved sham trials where no stimulation is applied.
Reaction times will be quantified in milliseconds.
|
1 Hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intracranial EEG
Time Frame: Intracranial EEG will be collected simultaneously when the participants perform the task. 1 Hour
|
Spectral analysis and functional connectivity analysis of electrophysiology data will be performed using methods like multi-taper fft, wavelets, phase locking, Granger causality etc.
The measures will be compared between sham and stimulation trials to identify if stimulation enhances neuronal entrainment.
The correlation between the measures described above and the task performance will also be estimated.
|
Intracranial EEG will be collected simultaneously when the participants perform the task. 1 Hour
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Facial Recognition Task Performance - Accuracy
Time Frame: 1 Hour
|
Participants who consent will be administered this task.
On a given trial, participants will be presented with images of two faces side-by-side.
The faces will either match in terms of emotion category (e.g., 2 anger faces) or not (e.g., an anger face and a fear face).
Faces presented together will always be of the same gender but different identities.
Participants will be asked to determine whether the two faces presented depict the same emotion category.
Participants will have 5 seconds to make the decision and indicate by pressing a key in the keyboard.
Accuracy will be quantified in percent correct.
|
1 Hour
|
Facial Recognition Task Performance - Reaction Time
Time Frame: 1 Hour
|
Participants who consent will be administered this task.
On a given trial, participants will be presented with images of two faces side-by-side.
The faces will either match in terms of emotion category (e.g., 2 anger faces) or not (e.g., an anger face and a fear face).
Faces presented together will always be of the same gender but different identities.
Participants will be asked to determine whether the two faces presented depict the same emotion category.
Participants will have 5 seconds to make the decision and indicate by pressing a key in the keyboard.
Reaction times will be quantified in milliseconds.
|
1 Hour
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Hae Won Shin, MD, University of North Carolina, Chapel Hill
- Principal Investigator: Flavio Frohlich, PhD, University of North Carolina, Chapel Hill
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-2710
- 1R01MH124387 (U.S. NIH Grant/Contract)
- 1R21NS094988 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Study Data/Documents
-
Summary Data Set
Information comments: Dataset supporting Alagapan et al. 2016 PLoS Biology
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Neuroelectrics CorporationRecruitingEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
University Hospital, LilleUnknownFocal Epilepsy | Epilepsy IntractableFrance
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsNot yet recruitingEpilepsy, Drug ResistantChina
Clinical Trials on Direct Cortical Stimulation Sham
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Not yet recruitingEpilepsy | Working MemoryUnited States
-
Shirley Ryan AbilityLabNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Nonfluent AphasiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); University of HoustonRecruitingBrain Neoplasm | Metastatic Malignant Neoplasm in the Brain | Recurrent Brain NeoplasmUnited States
-
Shirley Ryan AbilityLabRecruiting
-
Northstar NeuroscienceTerminatedDepressive Disorder | DepressionUnited States
-
I.R.C.C.S. Fondazione Santa LuciaUniversità degli studi di Roma Foro ItalicoRecruitingStroke | Stroke, IschemicItaly
-
McLaren Regional Medical CenterKettering UniversityCompleted
-
Huashan HospitalShanghai Zhongshan Hospital; Huashan Hospital North, Fudan UniversityNot yet recruiting
-
Federal University of ParaíbaUnknown
-
D'Or Institute for Research and EducationCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsCompleted